PRKCI and melanoma: Next, we investigated the impact of specific inhibition of each of the three PKC isozymes (PKCα, PKCε and PKCι) that we showed to be upregulated and phosphorylated in BRAFi-R melanoma cells (Figure 8A–C) on MARCKS activation in A375-R2 cells.